Morgan Dempsey Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$9.6K 159
2025
Q3
$9.6K Hold
100
﹤0.01% 133
2025
Q2
$8.79K Hold
100
﹤0.01% 132
2025
Q1
$8.99K Buy
+100
New +$8.95K ﹤0.01% 115
2024
Q4
Sell
-100
Closed -$9K 139
2024
Q3
$9K Hold
100
﹤0.01% 111
2024
Q2
$7.87K Buy
+100
New +$8.2K ﹤0.01% 99
2024
Q1
Sell
-100
Closed -$8.24K 115
2023
Q4
$8.24K Hold
100
﹤0.01% 102
2023
Q3
$7.84K Buy
+100
New +$8.37K ﹤0.01% 99

Other funds holding MDT

Morgan Dempsey Capital Management's MDT Position: Q2 2026 in Review

Morgan Dempsey Capital Management increased its Medtronic (MDT) stake by 3% in Q2 2026, buying an estimated $143K and bringing the position to 61,417 shares worth $4.85M. The position accounts for 2.08% of the portfolio, ranked #31.

Morgan Dempsey Capital Management first reported a position in MDT in Q2 2016 and has held it in 15 quarters since. The position peaked at $9.71M in Q4 2023. 1,229 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Morgan Dempsey Capital Management held 61,417 shares of Medtronic worth $4.85M as of Q2 2026.
  • Morgan Dempsey Capital Management bought 1,777 Medtronic shares in Q2 2026, an estimated $143K.
  • Medtronic made up 2.08% of Morgan Dempsey Capital Management's portfolio in Q2 2026, its #31 holding.
  • Morgan Dempsey Capital Management first reported a position in Medtronic in Q2 2016 and has held it in 15 quarters since.
  • Morgan Dempsey Capital Management's Medtronic position peaked at $9.71M in Q4 2023.
  • 1,229 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Morgan Dempsey Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.